This Article Free Full Text (Free PDF) Free References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Moore, M. A. Articles by Ito, N. Search for Related Content PubMed PubMed Citation Articles by Moore, M. A. Articles by Ito, N. Pubmed/NCBI databases Substance via MeSH Social Bookmarking                         What's this?

Commentary

Marriage of a Medium-Term Liver Model to Surrogate Markers—A Practical Approach for Risk and Benefit Assessment

Division of Chemotherapy, National Cancer Research Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104, Japan

Hiroyuki Tsuda

Division of Chemotherapy, National Cancer Research Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104, Japan

Seiko Tamano

First Department of Pathology

Akihiro Hagiwara

First Department of Pathology

Katsumi Imaida

First Department of Pathology

Tomoyuki Shirai

First Department of Pathology

Nobuyuki Ito

President, Nagoya City University, 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467, Japan

The need for a reliable medium-term alternative to traditional long-term rodent test protocols for carcinogen risk assessment is pressing given the immense variety of compounds being developed for introduction into the human environment. The established lack of a complete correlation between mutagenicity and carcinogenicity means that recourse must be made to an in vivo model. Optimally, this model should be able to detect not only complete carcinogenic or promoting potential but also any ability to inhibit neoplasia. In order to be effective, it must take into account the available detailed knowledge on mechanisms of action of carcinogens and modulating agents. The Ito model, for which a uniquely comprehensive set of background data has already been accumulated, has a solid scientific basis; this model utilizes quantitative data for glutathione S transferase-positive foci as the preneoplasia-based surrogate end point (PSE). A very practical candidate for routine application, its predictive power, its flexibility, and its capacity to incorporate a range of mechanism-based surrogate end points (MSEs) provide a powerful tool for attainment of the twin goals of detecting carcinogenic agents and identifying promising chemopreventors.

Toxicologic Pathology, Vol. 27, No. 2, 237-242 (1999)
DOI: 10.1177/019262339902700211


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				N. Uda, N. Kashimoto, I. Sumioka, E. Kyo, S.-i. Sumi, and S. Fukushima Aged Garlic Extract Inhibits Development of Putative Preneoplastic Lesions in Rat Hepatocarcinogenesis J. Nutr., March 1, 2006; 136(3): 855S - 860S. [Abstract] [Full Text] [PDF]